Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
INE963 / Novartis
PLATINUM, NCT05750628: Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria	Recruiting	2	327	RoW	INE963, KAE609 (Cipargamin), SoC (Coartem), KLU156	Novartis Pharmaceuticals	Uncomplicated Plasmodium Falciparum Malaria	04/26	05/26
NCT04896632: Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants	Terminated	1	64	Europe	INE 963, Placebo	Novartis Pharmaceuticals	Healthy Volunteers	11/22	11/22